5521 - 5530 of 7939 Results
Title
Year
-
OPENTitle: Dual role of USP 30 in controlling basal pexophagy and mitophagyJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745595Best OA location URL: https://doi.org/10.15252/embr.201745595Citation Count: 126
-
RESTRICTEDTitle: Tau-targeting therapies for Alzheimer diseaseJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 7Start Page: 399End Page: 415Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-018-0013-zBest OA location URL: https://europepmc.org/articles/pmc6463489?pdf=renderCitation Count: 726
-
OPENTitle: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 607End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4Best OA location URL: https://europepmc.org/articles/pmc6123262?pdf=renderCitation Count: 126
-
OPENTitle: Consensus for the measurement of the camptocormia angle in the standing patientJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.013Best OA location URL: https://zenodo.org/records/3873641/files/Consensus_Paper.pdfCitation Count: 53
- Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structure2018OPENTitle: Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structureJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13073-018-0551-4Best OA location URL: https://genomemedicine.biomedcentral.com/track/pdf/10.1186/s13073-018-0551-4.pdfCitation Count: 57
-
OPENTitle: A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 56Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.001Best OA location URL: http://www.prd-journal.com/article/S1353802018302608/pdfCitation Count: 99
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/records/3873759/files/system_appendPDF_proof_hi.pdfCitation Count: 16
- Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein2018OPENTitle: Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synucleinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 117Issue #:Start Page: 170End Page: 180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.05.018Best OA location URL: https://europepmc.org/articles/pmc6051902?pdf=renderCitation Count: 31
-
RESTRICTEDTitle: Gene Therapy Strategies to Restore ER Proteostasis in DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 26Issue #: 6Start Page: 1404End Page: 1413Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2018.04.004Best OA location URL: https://doi.org/10.1016/j.ymthe.2018.04.004Citation Count: 35
- Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?2018RESTRICTEDTitle: Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?Journal Name: ToxiconPublisher: Elsevier BVVol: 147Issue #:Start Page: 89End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.toxicon.2017.09.004Best OA location URL: https://europepmc.org/articles/pmc5839920?pdf=renderCitation Count: 49